Catalent Finalizes Schorndorf Plant Development Project
The clinical supply facility undergoes a $25 million expansion, welcoming 32,000 more square feet of temperature-controlled storage.
Treating Rheumatoid Arthritis Patients With Biosimilars Versus Leflunomide: An Economic Evaluation
A study explores the cost-effectiveness of combining methotrexate with various drugs as a way to combat failed methotrexate monotherapy.
INCOG BioPharma Invests in Second Manufacturing Building on Indiana Campus
The construction of 100,000 square-foot facility will boost the site's filling capacity to 140 million units per year.
How State Privacy Laws Are Shaping DTC and HCP Marketing Strategies
Why they are a game changer, and ways to a adapt to a new era of state privacy regulations.
Merck Finalizes EyeBio Purchase
The acquisition in the ophthalmology space features a $1.3 billon cash payment, with the potential for an additional $1.7 billion if various milestones are met.
The Relationship Between Patients and Drug Shortages
In an interview with Pharma Commerce editor Nicholas Saraceno, Peter Ax, UpScriptHealth’s founder and CEO, discusses how patients are affected by these supply chain bottlenecks, along with ways to mitigate these complications.
Rentschler Biopharma SE’s New Advanced Production Line Now Fully Operational
New production line represents Rentschler Biopharma SE’s biggest investment in its 150-year history.
The Current Landscape of Drug Shortages
In an interview with Pharma Commerce editor Nicholas Saraceno, Peter Ax, UpScriptHealth's founder and CEO, offers his thoughts surrounding the lack of supply.
The State of Patient Support Services in Today’s Landscape
Why these programs require a hybrid approach that combines technology and human connection.
MedPharm, Tergus Pharma Join Forces
The merger combines the companies under the MedPharma name, creating a topical and transepithelial CDMO in the process.
Determining Drug Development Costs in the United States
An economic evaluation study assesses these costs by therapeutic class, while identifying trends in pharma R&D intensity over time.
SGS North America Strengthens Its Biologics Testing Services
Expansion of these offerings will occur at the company’s 60,000 square-foot Lincolnshire Center of Excellence
Air Freight Demand Continues for May
Double-digit, year-on-year growth is now on a six-month streak.
Comparing Bariatric Metabolic Surgery, Glucagon-Like Peptide-1 Receptor Agonists Mortality Among Patients with Obesity and Diabetes
An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.
UPS Healthcare Financially Commits Over $21.6 Million Toward Cold Chain Fleet
The investment is expected to help enhance the company temperature-controlled services in the Netherlands, France, Italy, and Hungary.
FDA Approves Pyzchiva for Use in the United States
The Stelara biosimilar will be commercialized by Sandoz, and is expected to launch by February 2025 for multiple indications, including for the treatment of adult patients with active psoriatic arthritis.
Genezen Purchases uniQure’s Gene Therapy Operations in Massachusetts
The deal provides the CDMO with ownership of the Lexington facility, allowing for late-phase and commercial gene therapy development and manufacturing of a branded severe Hemophilia B product.
Analyzing the Effects of Respiratory Syncytial Virus Pre- and Post-Pandemic
A cross-sectional study evaluates the difference in clinical outcomes and demographics between pediatric RSV patients during these multiple timeframes.
Aurigene, Edity Introduce Cell Therapy Collaboration
The CRDMO will contribute cell discovery services that will benefit clinical development of novel technologies.
Kite to Assess Cellares’ Automated Manufacturing Platform
Following the evaluation, the company will decide whether it wants to move forward with the IDMO’s automated, end-to-end, cell therapy manufacturing platform.
Veranova Expands Its Financial Commitment Toward Growing Highly Potent API Services
The company’s latest investment—featuring new cGMP suites at its Devens, MA plant—is valued at $30 million.
Novo Nordisk Financially Commits $4.1 Billion Toward Growing US Manufacturing Capabilities
The North Carolina project adds 1.4 million square feet of dedicated production space for aseptic manufacturing and finished production processes.
Barriers Encountered by Patients While Making Cancer Care Clinic Appointments
A cross-sectional audit study determines how racial and ethnic disparities—among English, Mandarin, and Spanish-speaking patients—can impact access.
McKesson, Independent Pharmacy Cooperative Reach Drug Supply Agreement
The deal offers member pharmacies two pricing options, which will take effect Aug. 1.
The Association Between 340B Program Involvement and Availability of Hospital Services
A longitudinal observational study examined whether the program was related to access to hospital-based services, while determining if that association differs by hospital ownership.
Charles River, Gates Institute Strike Lentiviral Vector Manufacturing Deal
The agreement will look to further develop cell and gene therapies for the treatment of hematological cancers.
Differences in Patient Portal Engagement Among Hypertension Patients
A retrospective study investigates whether use of these portals can be defined by clinical and sociodemographic data.
ProBio Opens New Viral Vector Production Plant in the Garden State
The Hopewell facility—which will serve as the CDMO’s North American hub—is expected to help accelerate the cell and gene therapy delivery process.
ANI Pharmaceuticals Expands Rare Disease Offerings
The company acquires Alimera Sciences for $381 million upfront, while establishing its interest in ophthalmology.
Investigating the Cost-Effectiveness of Durvalumab
A study examines the economical validity of using this therapy as a treatment for unresectable stage III non–small cell lung cancer.
